Wordt geladen...
Cannabinoid CB(2) Agonist GW405833 Suppresses Inflammatory and Neuropathic Pain through a CB(1) Mechanism that is Independent of CB(2) Receptors in Mice
GW405833, widely accepted as a cannabinoid receptor 2 (CB(2)) agonist, suppresses pathologic pain in preclinical models without the unwanted central side effects of cannabinoid receptor 1 (CB(1)) agonists; however, recent in vitro studies have suggested that GW405833 may also behave as a noncompetit...
Bewaard in:
| Gepubliceerd in: | J Pharmacol Exp Ther |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
The American Society for Pharmacology and Experimental Therapeutics
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5502377/ https://ncbi.nlm.nih.gov/pubmed/28592614 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.117.241901 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|